• To understand the federal Drug Abuse Treatment Act (DATA) of 2000 and the subsequent revisions that lists the criteria needed for Office Based Opioid Treatment (OBOT) utilizing buprenorphine for opioid dependence and the new changes/guidelines
• To distinguish between spontaneous withdrawal and precipitated withdrawal and the appropriate methods of buprenorphine induction
• To describe and contrast the functions of full mu agonists, partial agonists and antagonists
• To describe the basic approach used in at least three different types of non-pharmacological treatment of opioid dependence
• To describe three symptoms of opioid withdrawal or intoxication that mimic symptoms of a psychiatric disorder
• To list the criteria for establishing the diagnosis of opioid dependence
• To list at least three situations in which patient information, with patient identity, can be shared under current laws protecting the patient’s confidentiality
• To understand and minimize buprenorphine misuse and diversion. To be aware of the issues of drug interactions of buprenorphine and pediatric exposures

This course has been reviewed and is acceptable for 4 credits of AOA Category 1A by the AOA CCME. It has also been reviewed and is acceptable for 4 Prescribed credit(s) by the American Academy of Family Physicians.

Physicians should claim only the credit commensurate with the extent of their participation in the activity. AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed credit, not as Category 1.